Dengue vaccine study for healthy older adults
Part of Infections clinical trials.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 79 years old.
- You are generally healthy, even if you have had dengue before.
- You are willing to get blood drawn, fill out a diary, and attend study visits.
- If you are a woman who could become pregnant, you must use birth control and not be pregnant or breastfeeding.
- You cannot have a weak immune system due to conditions like cancer, HIV, or an organ transplant.
- You have not had a severe allergic reaction to a vaccine before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving two vaccines (one for dengue, one for chikungunya) at the same time is as safe and effective as giving them separately. It may be a good option if you haven't been exposed to these viruses and are generally healthy.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
This study tests a controlled dengue infection in people who already have immunity to some types of dengue. It aims to understand how the immune system responds and to help develop better vaccines. You may qualify if you are a healthy adult aged 18-40 and have evidence of prior dengue exposure to certain virus types.
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This trial looks at a dengue vaccine strategy in children ages 9 to 17 in Martinique and Guadeloupe. It may help protect kids from dengue, based on how the vaccine is accepted and how the study is carried out.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.